Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Yahoo
Monday, November 10, 2014 - 11:05am
tags:
FDA, Amgen, evolocumab
Alexion Pharma co-founder Squinto to retire
Yahoo/AP
Monday, November 10, 2014 - 11:03am
tags:
Alexion
Justice Department Probes Generic Competition After Price Hike Reports
WSJ Pharmalot
Monday, November 10, 2014 - 11:00am
tags:
DOJ, generics, Impax Laboratories, Lannett
Ebola Contracts Worth $2 Billion Could Benefit Drugmakers
Bloomberg
Monday, November 10, 2014 - 10:58am
tags:
ebola virus, JNJ, GSK
Is this MannKind Corporation's Worst Nightmare?
Motley Fool
Monday, November 10, 2014 - 9:46am
tags:
MannKind, Afrezza, diabetes, reimbursement
Class I recall for Covidien's Puritan 980 ventilator
Mass Device
Monday, November 10, 2014 - 9:14am
tags:
Covidien, devices, recalls, Puritan 980
Curis misses Street 3Q forecasts
Yahoo/AP
Monday, November 10, 2014 - 9:09am
tags:
Curis, earnings
The Inaccurate And Unfair WHO Attack On Pharma Ebola Efforts
Forbes
Monday, November 10, 2014 - 9:03am
tags:
WHO, ebola virus, JNJ
Inovio posts 3Q loss
Yahoo/AP
Monday, November 10, 2014 - 8:16am
tags:
Inovio, earnings
Orexigen beats 3Q profit forecasts
Yahoo/AP
Monday, November 10, 2014 - 8:12am
tags:
Orexigen, earnings
Severe Epileptic Patients in Coma Respond to Sage Therapeutics Experimental Drug
TheStreet.com
Monday, November 10, 2014 - 8:11am
tags:
epilepsy, SAGE Therapeutics, SAGE-547
Sun Pharma hits all-time high after unit Taro's results
Yahoo/Reuters
Monday, November 10, 2014 - 8:07am
tags:
Sun Pharma, Taro, earnings
Dendreon Files for Chapter 11 Bankruptcy Protection
Bloomberg
Monday, November 10, 2014 - 7:58am
tags:
Dendreon, bankruptcy
Merck’s Four-Week Hepatitis C Regimen Fails to Top Gilead
Bloomberg
Monday, November 10, 2014 - 7:57am
tags:
hepatitis C, Merck, Gilead Sciences, grazoprevir, elbasvir, Sovaldi
Intercept Pharmaceuticals Below $180: Mega Millions Vanish
Forbes
Sunday, November 9, 2014 - 10:29am
tags:
Intercept Pharmaceuticals
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
Sunday, November 9, 2014 - 9:46am
tags:
hepatitis B, hepatitis, nonalcoholic steatohepatitis, Gilead, Galmed Pharmaceuticals, Raptor Pharmaceuticals, Conatus Pharmaceuticals
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Saturday, November 8, 2014 - 11:39am
tags:
diffuse large B-cell lymphoma, lymphoma, MorphoSys, MOR208
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients
Yahoo/BusinessWire
Saturday, November 8, 2014 - 11:35am
tags:
daclatasvir, sofosbuvir, hepatitis C, hepatitis, Bristol-Myers Squibb
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Saturday, November 8, 2014 - 10:39am
tags:
Achillion, ACH-3102, ACH-3422, HCV, hepatitis C
Neuralstem Among Our 'Best for 2015' Biotech Names
Yahoo/Zacks
Saturday, November 8, 2014 - 10:35am
tags:
Neuralstem

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.